News and Reports
-
Swixx completes strategic investment from SK Capital and Bain Capital Life Sciences to support continued gobal expansion
1 June 2026Download -
Curevo to be Acquired by Lilly to Advance Next-Generation Shingles Prevention
26 May 2026 -
Parabilis Medicines Announces Strategic Collaboration with Regeneron Pharmaceuticals to Advance Novel Antibody-Helicon™ Conjugates Across Multiple Therapeutic Areas
18 May 2026Download -
CellCentric Announces Oversubscribed $220m Series D Financing to Advance Pivotal Trials of Inobrodib in Multiple Myeloma
6 May 2026Download -
SnapCare and connectRN Join Forces to Provide Growth- Forward Workforce Solutions Powering Better Care
29 April 2026Download -
SWIXX Enters Into a Strategic Multiregional Distribution Partnership with BRIDGEBIO
30 March 2026Download -
Nuance Pharma Announces Approval of Ohtuvayre® (ensifentrine) in Hong Kong SAR, China
12 March 2026Download -
SWIXX BIOPHARMA EXPANDS PARTNERSHIP WITH ELI LILLY TO BRAZIL
4 March 2026Download -
ADARx Pharmaceuticals Presents Onvuzosiran Data Supporting Potential for Sustained Attack-Free Rates with Reduced Treatment Burden in Patients with HAE
27 February 2026Download -
SWIXX AND MADRIGAL ANNOUNCE EXCLUSIVE EUROPEAN PARTNERSHIP ON FIRST TARGETED THERAPY FOR MASH
3 February 2026Download -
Fangzhou Issues Positive Profit Forecast as AI-Driven Chronic Care Model Delivers First Full-Year Profita
26 January 2026Download -
CORXEL Announces $287 million Series D1 Financing to Further Advance Its Cardiometabolic Pipeline including Oral Small Molecule GLP-1 Receptor Agonist
22 January 2026Download -
NEURELIS PROVIDES BUSINESS UPDATE HIGHLIGHTING TRANSFORMATIONAL 2025 RESULTS
12 January 2026Download -
Parabilis Medicines Announces Oversubscribed $305 Million Financing to Support Ongoing FOG-001 (zolucatetide) Clinical Development Across a Broad Range of Tumors and Advance Pioneering Pipeline and Helicon Platform
8 January 2026Download -
Dren Bio Expands Strategic Collaboration with Sanofi to Develop Next-Generation B-Cell Depletion Therapy
15 December 2025Download -
SK CAPITAL INVESTS IN SWIXX BIOPHARMA TO ACCELERATE GLOBAL EXXPANSION
15 December 2025Download -
Mirum Pharmaceuticals Enters into Definitive Agreement to Acquire Bluejay Therapeutics, Expanding Global Leadership in Rare Disease
8 December 2025Download -
Electra Therapeutics Presents SURPASS Pivotal ELA026 Study Design and Highlights the Critical Unmet Need in Secondary Hemophagocytic Lymphohistiocytosis (sHLH) at the ASH 2025 Annual Meeting
2 December 2025Download -
SWIXX AND LUNDBECK PARTNERSHIP GOES LIVE
1 December 2025Download -
Valo Health Announces Collaboration with Merck KGaA, Darmstadt, Germany to Discover and Develop Novel Treatments for Parkinson’s Disease and Related Disorders
20 November 2025 -
Freenome Announces Exclusive Agreement with Roche to Expand Technology Collaboration and Develop and Commercialize Cancer Screening Tests Outside the U.S.
18 November 2025Download -
Numab Therapeutics and Kaken Pharmaceutical Announce Licensing and Co-development Agreement for Multispecific Antibody NM81 in Inflammatory Bowel Disease (IBD)
13 November 2025Download -
Fangzhou and Fosun Pharma Forge Strategic Alliance to Deliver AI-Powered Psoriasis Management
29 October 2025Download -
Electra Therapeutics Announces First Patients Dosed in the SURPASS Phase 2/3 Pivotal Study of ELA026 in Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
22 October 2025Download -
Electra Therapeutics Announces $183 Million Series C Financing to Advance First-in-Class SIRP-Targeted Therapies for Immune Disorders and Cancer
22 October 2025Download